In addition, the plasma proteome alterations identified unique features associated with respective disease, allowing the discovery of potential plasma biomarkers for differential diagnosis of COVID-19 and CAP-sepsis, among them TRIM21, PTN and CASP8. The gene discussed is PTN; the disease is COVID-19.